| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 9e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |